Back to BlackRock, Inc. BlackRock, Inc.

BDTXBDTX
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in BLACK DIAMOND THERAPEUTICS I

BlackRock, Inc. holds 3.9M shares of BDTX (BLACK DIAMOND THERAPEUTICS I), worth $7.2M as of 2026-Q2. The position was increased (+253.9% shares). BDTX represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$7.2M

Current Shares

3.9M

Total Value Change

-$284,357

Total Shares Change

+397,943

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.9M
+253.9%
$7.2M0.0%$1.85
44
2026-Q1
Increased
1.1M
+24.6%
$2.4M0.0%$2.30
22
2025-Q4
Decreased
888,260
-13.6%
$2.2M0.0%$2.49
0
2025-Q3
Decreased
1M
-5.8%
$3.9M0.0%$3.73
0
2025-Q2
Decreased
1.1M
-68.6%
$2.7M0.0%$2.35
0
2025-Q1
Decreased
3.5M
-1.3%
$5.4M0.0%$1.61
0
2024-Q4
New
3.5M
-
$7.5M0.0%$2.15
38

Other major holders of BDTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used